Clinical Trials Logo

Lung Cancer clinical trials

View clinical trials related to Lung Cancer.

Filter by:

NCT ID: NCT02784158 No longer available - Lung Cancer Clinical Trials

An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer

Start date: n/a
Phase: N/A
Study type: Expanded Access

The purpose of this study is to provide brigatinib for those patients with locally advanced and/or metastatic patients with ALK+ NSCLC on an expanded access basis due to their inability to meet eligibility criteria for on-going recruiting trials, inability to participate in other clinical trials (e.g., poor performance status, lack of geographic proximity), or because other medical interventions are not considered appropriate or acceptable.

NCT ID: NCT02781857 Recruiting - Lung Cancer Clinical Trials

Mass Spectral Fingerprinting in Lung Cancer

Start date: May 2016
Phase:
Study type: Observational

To answer the question whether a disease specific profile of breath in patients with lung cancer can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

NCT ID: NCT02777996 Completed - Lung Cancer Clinical Trials

Italian Lung Cancer Screening Trial (ITALUNG)

ITALUNG
Start date: September 2003
Phase: N/A
Study type: Interventional

ITALUNG is a RCT for the evaluation of the efficacy of lung cancer screening with low-dose Computer Tomography (LDCT) , carried out in three screening centers in Florence, Pisa and Pistoia districts of the Tuscany region of Italy. 3106 high risk subjects (age 55-69, smokers or ex-smokers) were recruited and randomized to the Active arm (Baseline + 3 annually repeated LDCT screening) or to the Passive arm, followed up in usual care (no screening reccomended ) All subjects were invited, if smokers, to consider smoking cessation practice. Follow-up for cause specific mortality and overall mortality and for lung cancer incidence was performed (actually at 9.3 years since randomization) . Blood and sputum samples were stored from the Active arm in a Biobank, with 1304 subjects enrolled in the Italung Biomarker study.

NCT ID: NCT02771756 Recruiting - Breast Cancer Clinical Trials

The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

Start date: May 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to research more reasonable and safe methods of nutritional support to improve the nutritional status of tumor patients, which guarantees the anti-tumor treatment such as chemotherapy.

NCT ID: NCT02771470 Completed - Lung Cancer Clinical Trials

Intestinal Microflora in Lung Cancer After Chemotherapy

Start date: September 2014
Phase: Phase 1
Study type: Interventional

Probiotics modulate the gut microflora and immune status in lung cancer who need chemotherapy.

NCT ID: NCT02769299 Completed - Breast Cancer Clinical Trials

Cardiotoxicity of Radiation Therapy (CTRT)

Start date: June 2, 2015
Phase:
Study type: Observational

The overall objective of this proposal is to determine the utility of sensitive imaging and biomarker measures in detecting subclinical cardiotoxicity across a spectrum of radiation doses to the heart. We will focus specifically on patients receiving photon or proton chest radiotherapy. Our broad working hypothesis is that RT induces early, subclinical CV injury, as evidenced by cardiomyocyte inflammation and necrosis, and worsening CV function.

NCT ID: NCT02768337 Terminated - Breast Cancer Clinical Trials

Cambridge Brain Mets Trial 1

CamBMT1
Start date: March 10, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Proof of principle phase 1b / randomised phase 2 study of afatinib penetration into cerebral metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy.

NCT ID: NCT02764866 Completed - Lung Cancer Clinical Trials

Sleep Apnea in Lung Cancer: A Prospective Study

SAIL
Start date: February 2016
Phase: N/A
Study type: Interventional

The study seeks to determine the prevalence of sleep disordered breathing in a population of patients diagnosed with lung cáncer.

NCT ID: NCT02763761 Withdrawn - Lung Cancer Clinical Trials

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Start date: August 16, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the effects of Infliximab and oral prednisone versus methylprednisolone and oral prednisone in patients with melanoma, lung cancer, or renal cell carcinoma who have immune related Grade 3-4 diarrhea for up to 3 days or persistent Grade 2 diarrhea for more than 5 days after treatment with Yervoy and/or Opdivo

NCT ID: NCT02759679 Terminated - Lung Cancer Clinical Trials

Canine-Assisted Profiling of Lung Cancer From Human Breath

Start date: May 2016
Phase: N/A
Study type: Interventional

The study aims to optimize and define a reproducible and non-invasive method for canine assisted lung cancer detection, using human breath samples from patients and controls for training and testing purposes.